CME Information: 2.0 Credits
Release Date: January 1, 2020
Expiration Date: January 21, 2021
You must be logged in and own this product in order to post comments.
Guidelines for Performance, Interpretation, and Application of Stress Echocardiography in Ischemic Heart Disease: From the American Society of Echocardiography
CME Information: 2 Credits
Release date: January 2020 Valid through: January 2021
Introduction/Statement of Need:
Since the 2007 publication of the American Society of Echocardiography (ASE) guidelines for stress echocardiography, new information has become available about the methodology of stress echocardiography, including test protocols, standards for interpretation (including quantitative methods of assessment and application of strain rate imaging), appropriateness of testing, comparison with other modalities for assessing ischemic heart disease (IHD), safety of stress echocardiography, application of the technique in children and special populations, prognostic value, and role of ultrasound enhancing agents (UEA) and perfusion imaging. This updated document includes this new information and summarizes current practice recommendations and training requirements. Additionally, a class of recommendation and level of evidence for diagnostic strategies using stress echocardiography have been added. These recommendations are made according to the 2015 American College of Cardiology/American Heart Association clinical practice guidelines. Speciﬁc recommendations and main points are identiﬁed in bold. Although stress echocardiography may be applied in the assessment of many diverse cardiac conditions, the current document describes its applications in IHD.
This activity is designed for all cardiac sonographers and cardiovascular physicians with a primary interest and knowledge base in the field of echocardiography; in addition, residents, researchers, clinicians, intensivists, and other medical professionals.
At the end of this activity the reader will better be able to
The American Society of Echocardiography is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American Society of Echocardiography designates this enduring material for a maximum of 2 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to X MOC point in the American Board of Internal Medicine's (ABIM). Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
ARDMS, CCI and Sonography Canada recognize ASE’s certificates and have agreed to honor the credit hours toward their registry requirements for sonographers.
The American Society of Echocardiography is committed to ensuring that its educational mission and all sponsored educational programs are not influenced by the special interests of any corporation or individual, and its mandate is to retain only those authors whose financial interests can be effectively resolved to maintain the goals and educational integrity of the activity. While a monetary or professional affiliation with a corporation does not necessarily influence an author’s presentation, the Essential Areas and policies of the ACCME require that any relationships that could possibly conflict with the educational value of the activity be resolved prior to publication and disclosed to the audience. Disclosures of faculty and commercial support relationships, if any, have been indicated.
Patricia A. Pellikka, MD, FASE, Chair, Adelaide Arruda-Olson, MD, PhD, FASE,
Farooq A. Chaudhry, MD, FASE,* Ming Hui Chen, MD, MMSc, FASE, Jane E. Marshall, RDCS, FASE, Thomas R. Porter, MD, FASE, and Stephen G. Sawada, MD, Rochester, Minnesota; New York, New York; Boston, Massachusetts; Omaha, Nebraska; Indianapolis, Indiana
Reviewers: This document was reviewed by members of the 2018-2019 ASE Guidelines and Standards Committee, ASE Board of Directors, and ASE Executive Committee. Reviewers included Bonita Anderson, MAPPLSC, DMU, AMS, FASE, ACS, Azin Alizadehasl, MD, FASE, Scott D. Choyce, RDCS, RVT, RDMS, FASE, Craig Fleishman, MD, FASE, Benjamin Freed, MD, FASE, Mark K. Friedberg, MD, FASE, Edward Gill, MD, FASE, Robi Goswami, MD, FASE, Renuka Jain, MD, FASE, Pei-Ni Jone, MD, FASE, Stephen H. Little, MD, FASE, Judy Mangion, MD, FASE, Anuj Mediratta, MD, FASE, Andy Pellett, PhD, RCS, RDCS, FASE, Dermot Phelan, MD, PhD, FASE, Juan Carlos Plana, MD, FASE, Geoffrey A. Rose, MD, FASE, David S. Rubenson, MD, FASE, Fadi Shamoun, MD, FASE, David H. Wiener, MD, FASE, and Megan Yamat, RDCS, RCS, FASE. The authors appreciate the technical support of Ms. Tessa Flies with manuscript preparation.
According to ACCME policy, ASE implemented mechanisms to resolve all conflicts of interest prior to the planning and implementation of this activity.
The following authors reported no actual or potential conflicts of interest in relation to this document:
Ming Hui Chen, MD, MMSc, FASE; Jane E. Marshall, RDCS,FASE; Stephen G. Sawada, MD.
The following authors reported relationships with one or more commercial interests in relation to this document:
Farooq A. Chaudhry, MD, FASE, received a research grant, a restricted fellowship grant, and consulted for Bracco Diagnostics, a research grant from GE Healthcare, and consulted for Lantheus Medical Imaging; Patricia A. Pellikka, MD, FASE, served on the advisory board for Bracco Diagnostics and received research grants from GE Healthcare and Lantheus Medical Imaging, with money paid to her institution; Thomas R. Porter, MD, FASE, received a research grant and served on the speaker’s bureau for Bracco Diagnostics, and received a research grant from Lantheus Medical Imaging. Dr. Adelaide Arruda-Olson was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health (award K01HL124045). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
The following CME reviewers, ASE Staff and JASE editors reported no actual or potential conflicts of interest in relation to this document:
Dr. Bhawna Arya MD, FASE, Dr. Matthew Parker MD, FASE, Jennifer Goss ASE, and Priscilla Peters
The following CME reviewers, ASE Staff and JASE editors reported relationships with one or more commercial interests:
Method of Participation: Online Only
Estimated Time to Complete this Activity: 2 hours
Receiving CME Credit:
To receive online CME credit for this activity, read the full activity then complete the posttest and evaluation. A score of 70% or higher is required for successful completion. You will be able to print your CME certificate immediately following successful completion of the posttest and evaluation.
You will need a compatible browser like Mozilla FireFox, Google Chrome or safari to view the content. Internet Explorer may not work.
This report is made available by ASE as a courtesy reference source for members. This report contains recommendations only and should not be used as the sole basis to make medical practice decisions or for disciplinary action against any employee. The statements and recommendations contained in this report are primarily based on the opinions of experts, rather than on scientifically verified data. ASE makes no express or implied warranties regarding the completeness or accuracy of the information in this report, including the warranty of merchantability or fitness for a particular purpose. In no event shall ASE be liable to you, your patients, or any other third parties for any decision made or action taken by you or such other parties in reliance on this information. Nor does your use of this information constitute the offering of medical advice by ASE or create any physician patient relationship between ASE and your patients or anyone else.
Copyright American Society of Echocardiography. Questions? Contact us at email@example.com
Abraham TP, Belohlavek M, Thomson HL, Pislaru C, Khandheria B,
Seward JB, et al. Time to onset of regional relaxation: feasibility, variability
and utility of a novel index of regional myocardial function by strain rate
imaging. J Am Coll Cardiol 2002;39:1531-7.
2. Voigt JU, Exner B, Schmiedehausen K, Huchzermeyer C, Reulbach U,
Nixdorff U, et al. Strain-rate imaging during dobutamine stress echocardiography
provides objective evidence of inducible ischemia. Circulation
3. Hanekom L, Cho GY, Leano R, Jeffriess L, Marwick TH. Comparison of
two-dimensional speckle and tissue Doppler strain measurement during
dobutamine stress echocardiography: an angiographic correlation. Eur
Heart J 2007;28:1765-72.
4. IngulCB, Stoylen A, Slordahl SA,Wiseth R, Burgess M, Marwick TH. Automated
analysis of myocardial deformation at dobutamine stress echocardiography:
an angiographic validation. JAmColl Cardiol 2007;49:1651-9.
5. Weidemann F, Jung P, Hoyer C, Broscheit J, Voelker W, Ertl G, et al. Assessment
of the contractile reserve in patients with intermediate coronary lesions:
a strain rate imaging study validated by invasive myocardial
fractional flow reserve. Eur Heart J 2007;28:1425-32.
6. Takagi T, Takagi A, Yoshikawa J. Detection of coronary artery disease using
delayed strain imaging at 5 min after the termination of exercise stress:
head to head comparison with conventional treadmill stress echocardiography.
J Cardiol 2010;55:41-8.
7. Nagy AI, Sahlen A, Manouras A, Henareh L, da Silva C, Gunyeli E, et al.
Combination of contrast-enhanced wall motion analysis and myocardial
deformation imaging during dobutamine stress echocardiography. Eur
Heart J Cardiovasc Imaging 2015;16:88-95.
8. Ng AC, Sitges M, Pham PN, Tran da T, Delgado V, Bertini M, et al. Incremental
value of 2-dimensional speckle tracking strain imaging to wall motion
analysis for detection of coronary artery disease in patients
undergoing dobutamine stress echocardiography. Am Heart J 2009;158:
9. Celutkiene J, Zakarkaite D, Skorniakov V, Zvironaite V, Grabauskiene V,
Burca J, et al. Quantitative approach using multiple single parameters
versus visual assessment in dobutamine stress echocardiography. Cardiovasc
10. Yu Y, Villarraga HR, Saleh HK, Cha SS, Pellikka PA. Can ischemia and dyssynchrony
be detected during early stages of dobutamine stress echocardiography
by 2-dimensional speckle tracking echocardiography? Int J
Cardiovasc Imaging 2013;29:95-102.
11. Hwang HJ, Lee HM, Yang IH, Lee JL, Pak HY, Park CB, et al. The value of
assessing myocardial deformation at recovery after dobutamine stress
echocardiography. J Cardiovasc Ultrasound 2014;22:127-33.
12. Cusma-Piccione M, Zito C, Oreto L, D’Angelo M, Tripepi S, Di Bella G,
et al. Longitudinal strain by automated function imaging detects singlevessel
coronary artery disease in patients undergoing dipyridamole stress
echocardiography. J Am Soc Echocardiogr 2015;28:1214-21.
13. Aggeli C, Lagoudakou S, Felekos I, Panagopoulou V, Kastellanos S,
Toutouzas K, et al. Two-dimensional speckle tracking for the assessment
of coronary artery disease during dobutamine stress echo: clinical tool
or merely research method. Cardiovasc Ultrasound 2015;13:43.
14. Joyce E, Hoogslag GE, Al Amri I, Debonnaire P, Katsanos S, Bax JJ, et al.
Quantitative dobutamine stress echocardiography using speckle-tracking
analysis versus conventional visual analysis for detection of significant coronary
artery disease after ST-segment elevation myocardial infarction. J
Am Soc Echocardiogr 2015;28:1379-13789 e1.
15. Uusitalo V, Luotolahti M, Pietila M, Wendelin-Saarenhovi M, Hartiala J,
Saraste M, et al. Two-dimensional speckle-tracking during dobutamine
stress echocardiography in the detection of myocardial ischemia in patients
with suspected coronary artery disease. J Am Soc Echocardiogr
16. Rumbinaite E, Zaliaduonyte-Peksiene D, Lapinskas T, Zvirblyte R,
Karuzas A, Jonauskiene I, et al. Early and late diastolic strain rate vs global
longitudinal strain at rest and during dobutamine stress for the assessment
of significant coronary artery stenosis in patients with a moderate and high
probability of coronary artery disease. Echocardiography 2016;33:
17. KimMN, Kim SA, Kim YH, Hong SJ, Park SM, ShinMS, et al. Head to head
comparison of stress echocardiography with exercise electrocardiography
for the detection of coronary artery stenosis in women. J Cardiovasc Ultrasound
18. Abdelmoneim SS, Mulvagh SL, Xie F, O’Leary E, Adolphson M,
Omer MA, et al. Regadenoson stress real-time myocardial perfusion echocardiography
for detection of coronary artery disease: feasibility and accuracy
of two different ultrasound contrast agents. J Am Soc Echocardiogr
19. Neglia D, Rovai D, Caselli C, Pietila M, Teresinska A, Aguade-Bruix S, et al.
Detection of significant coronary artery disease by noninvasive anatomical
and functional imaging. Circ Cardiovasc Imaging 2015;8.
20. WongCB, Leung SE, Fukuyanagi S. A novel method to risk stratify patients
undergoing exercise stress echocardiography using a set of combined
criteria. Int J Angiol 2015;24:35-40.
21. Mordi I, Stanton T, Carrick D, McClure J, Oldroyd K, Berry C, et al.
Comprehensive dobutamine stress CMR versus echocardiography in
LBBB and suspected coronary artery disease. JACC Cardiovasc Imaging
22. Shaikh K, Wang DD, Saad H, Alam M, Khandelwal A, Brooks K, et al.
Feasibility, safety and accuracy of regadenoson-atropine (REGAT) stress
echocardiography for the diagnosis of coronary artery disease: an angiographic
correlative study. Int J Cardiovasc Imaging 2014;30:515-22.
23. Miszalski-Jamka T, Kuntz-Hehner S, Tiemann K, Karwat K, Kostkiewicz M.
Quantitative myocardial contrast supine bicycle stress echocardiography
for detection of coronary artery disease. Echocardiography 2013;30:
24. Caiati C, LeperaME, Carretta D, Santoro D, Favale S. Head-to-head comparison
of peak upright bicycle and post-treadmill echocardiography in
detecting coronary artery disease: a randomized, single-blind crossover
study. J Am Soc Echocardiogr 2013;26:1434-43.
25. Chandraratna PA, Kuznetsov VA, Mohar DS, Sidarous PF, Scheutz J,
Krinochkin DV, et al. Comparison of squatting stress echocardiography
and dobutamine stress echocardiography for the diagnosis of coronary artery
disease. Echocardiography 2012;29:695-9.
26. Falcao SN, Rochitte CE, Junior WM, Quaglia L, Lemos PA, Sbano JC, et al.
Incremental value of perfusion over wall-motion abnormalities with the
use of dobutamine-atropine stress myocardial contrast echocardiography
and magnetic resonance imaging for detecting coronary artery disease.
27. Peteiro J, Bouzas-Mosquera A, Estevez R, Pazos P, Pineiro M, Castro-
Beiras A. Head-to-head comparison of peak supine bicycle exercise echocardiography
and treadmill exercise echocardiography at peak and at postexercise
for the detection of coronary artery disease. J Am Soc Echocardiogr
28. Aggeli C, Felekos I, Roussakis G, Kazazaki C, Lagoudakou S, Pietri P, et al.
Value of real-time three-dimensional adenosine stress contrast echocardiography
in patients with known or suspected coronary artery disease. Eur J
29. Mathias W Jr., Kowatsch I, Saroute AN, Osorio AF, Sbano JC,
Dourado PM, et al. Dynamic changes in microcirculatory blood flow during
dobutamine stress assessed by quantitative myocardial contrast echocardiography.
30. Arnold JR, Karamitsos TD, Pegg TJ, Francis JM, Olszewski R, Searle N, et al.
Adenosine stress myocardial contrast echocardiography for the detection
of coronary artery disease: a comparison with coronary angiography and
cardiac magnetic resonance. JACC Cardiovasc Imaging 2010;3:934-43.
31. Badano LP, Muraru D, Rigo F, Del Mestre L, Ermacora D, Gianfagna P,
et al. High volume-rate three-dimensional stress echocardiography to
assess inducible myocardial ischemia: a feasibility study. JAm Soc Echocardiogr
32. Gaibazzi N, Rigo F, Squeri A, Ugo F, Reverberi C. Incremental value of
contrast myocardial perfusion to detect intermediate versus severe coronary artery stenosis during stress-echocardiography. Cardiovasc Ultrasound
33. Gaibazzi N, Rigo F, Reverberi C. Detection of coronary artery disease by
combined assessment of wall motion, myocardial perfusion and coronary
flow reserve: a multiparametric contrast stress-echocardiography study. J
Am Soc Echocardiogr 2010;23:1242-50.
34. Lu C, Lu F, Fragasso G, Dabrowski P, Di Bello V, Chierchia SL, et al. Comparison
of exercise electrocardiography, technetium-99m sestamibi single
photon emission computed tomography, and dobutamine and dipyridamole
echocardiography for detection of coronary artery disease in hypertensive
women. Am J Cardiol 2010;105:1254-60.
35. Plonska-Gosciniak E, Lancellotti P, Kleinrok A, Gackowski A, Gasior Z,
Kowalik I, et al. Influence of gender on diagnostic accuracy of rapid atrial
and ventricular pacing stress echocardiography for the detection of coronary
artery disease: a multicenter study (Pol-RAPSE final results). J AmSoc
36. Hoffmann R, Altiok E, Nowak B, Heussen N, Kuhl H, Kaiser HJ, et al.
Strain rate measurement by Doppler echocardiography allows improved
assessment of myocardial viability inpatients with depressed left ventricular
function. J Am Coll Cardiol 2002;39:443-9.
37. Vitarelli A, Montesano T, Gaudio C, Conde Y, Cimino E, D’Angeli I, et al.
Strain rate dobutamine echocardiography for prediction of recovery after
revascularization in patients with ischemic left ventricular dysfunction. J
Card Fail 2006;12:268-75.
38. Fujimoto H, Honma H, Ohno T, Mizuno K, Kumita S. Longitudinal
Doppler strain measurement for assessment of damaged and/or hibernating
myocardium by dobutamine stress echocardiography in patients with
old myocardial infarction. J Cardiol 2010;55:309-16.
39. Bansal M, Jeffriess L, Leano R, Mundy J, Marwick TH. Assessment of
myocardial viability at dobutamine echocardiography by deformation
analysis using tissue velocity and speckle-tracking. JACC Cardiovasc Imaging
40. Rosner A, Avenarius D, Malm S, Iqbal A, Baltabaeva A, Sutherland GR,
et al. Persistent dysfunction of viable myocardium after revascularization
in chronic ischaemic heart disease: implications for dobutamine stress
echocardiography with longitudinal systolic strain and strain rate measurements.
Eur Heart J Cardiovasc Imaging 2012;13:745-55.
41. Ran H, Zhang PY, Fang LL, MaXW,Wu WF, Feng WF. Clinic value of twodimensional
speckle tracking combined with adenosine stress echocardiography
for assessment of myocardial viability. Echocardiography 2012;
42. Li L,Wang F, Xu T, Chen J,Wang C,Wang X, et al. The detection of viable
myocardium by low-dose dobutamine stress speckle tracking echocardiography
in patients with old myocardial infarction. J Clin Ultrasound
43. ChenMH, Abernathey E, Lunze F, Colan SD, O’Neill S, Bergersen L, et al.
Utility of exercise stress echocardiography in pediatric cardiac transplant
recipients: a single-center experience. J Heart Lung Transplant 2012;31:
44. Di Filippo S, Semiond B, Roriz R, Sassolas F, RaboissonMJ, Bozio A. Noninvasive
detection of coronary artery disease by dobutamine-stress echocardiography
in children after heart transplantation. J Heart Lung Transplant
45. Dipchand AI, Bharat W, Manlhiot C, Safi M, Lobach NE, McCrindle BW.
A prospective study of dobutamine stress echocardiography for the assessment
of cardiac allograft vasculopathy in pediatric heart transplant recipients.
Pediatr Transplant 2008;12:570-6.
46. Larsen RL, Applegate PM, Dyar DA, Ribeiro PA, Fritzsche SD, Mulla NF,
et al. Dobutamine stress echocardiography for assessing coronary artery disease
after transplantation in children. J Am Coll Cardiol 1998;32:515-20.
47. Maiers J, Hurwitz R. Identification of coronary artery disease in the pediatric
cardiac transplant patient. Pediatr Cardiol 2008;29:19-23.
48. Pahl E, Sehgal R, Chrystof D, Neches WH,WebbCL, DuffyCE, et al. Feasibility
of exercise stress echocardiography for the follow-up of children
with coronary involvement secondary to Kawasaki disease. Circulation
49. Noto N,AyusawaM,KarasawaK,Yamaguchi H, SumitomoN,OkadaT, et al.
Dobutamine stress echocardiography for detection of coronary artery stenosis
in children with Kawasaki disease. J Am Coll Cardiol 1996;27:1251-6.
50. Noto N, Kamiyama H, Karasawa K, Ayusawa M, Sumitomo N, Okada T,
et al. Long-term prognostic impact of dobutamine stress echocardiography
in patients with Kawasaki disease and coronary artery lesions: a 15-
year follow-up study. J Am Coll Cardiol 2014;63:337-44.
51. Ryerson AB, Border WL,Wasilewski-Masker K, Goodman M, Meacham L,
Austin H, et al. Assessing anthracycline-treated childhood cancer survivors
with advanced stress echocardiography. Pediatr Blood Cancer 2015;62:
52. ChenMH, Blackington LH, Zhou J, Chu TF, Gauvreau K, Marcus KJ, et al.
Blood pressure is associated with occult cardiovascular disease in prospectively
studied Hodgkin lymphoma survivors after chest radiation. Leuk
53. Brothers JA, McBride MG, Seliem MA, Marino BS, Tomlinson RS,
Pampaloni MH, et al. Evaluation of myocardial ischemia after surgical
repair of anomalous aortic origin of a coronary artery in a series of pediatric
patients. J Am Coll Cardiol 2007;50:2078-82.
54. Hasan BS, Lunze FI, McElhinney DB, Stantcheva E, Brown DW, Rhodes J,
et al. Exercise stress echocardiographic assessment of outflow tract and
ventricular function in patients with an obstructed right ventricular-topulmonary
artery conduit after repair of conotruncal heart defects. Am J
55. Pauliks LB, Brian Clark J, Rogerson A, DiPietro A, Myers JL, Cyran SE. Exercise
stress echocardiography after childhood Ross surgery: functional
outcome in 26 patients from a single institution. Pediatr Cardiol 2012;
56. Ciliberti P, McLeod I, Cairello F, Kaski JP, Fenton M, Giardini A, et al.
Semi-supine exercise stress echocardiography in children and adolescents:
feasibility and safety. Pediatr Cardiol 2015;36:633-9.
57. Kutty S, Olson J, Danford CJ, Sandene EK, Xie F, Fletcher SE, et al. Ultrasound
contrast and real-time perfusion in conjunction with supine bicycle
stress echocardiography for comprehensive evaluation of surgically corrected
congenital heart disease. Eur Heart J Cardiovasc Imaging 2012;
Journal of the American Society of Echocardiography
Volume- Number -
Pellikka et al 41.e10